Order Article Reprints

Montero-Calle A, Garranzo-Asensio M, Torrente-Rodríguez RM, Ruiz-Valdepeñas Montiel V, Poves C, Dziaková J, Sanz R, Díaz del Arco C, Pingarrón JM, Fernández-Aceñero MJ, et al. p53 and p63 Proteoforms Derived from Alternative Splicing Possess Differential Seroreactivity in Colorectal Cancer with Distinct Diagnostic Ability from the Canonical Proteins. Cancers. 2023; 15(7):2102. https://doi.org/10.3390/cancers15072102

Montero-Calle, Ana, María Garranzo-Asensio, Rebeca M. Torrente-Rodríguez, Víctor Ruiz-Valdepeñas Montiel, Carmen Poves, Jana Dziaková, Rodrigo Sanz, Cristina Díaz del Arco, José Manuel Pingarrón, María Jesús Fernández-Aceñero, and et al. 2023. "p53 and p63 Proteoforms Derived from Alternative Splicing Possess Differential Seroreactivity in Colorectal Cancer with Distinct Diagnostic Ability from the Canonical Proteins" Cancers 15, no. 7: 2102. https://doi.org/10.3390/cancers15072102

Montero-Calle, A., Garranzo-Asensio, M., Torrente-Rodríguez, R. M., Ruiz-Valdepeñas Montiel, V., Poves, C., Dziaková, J., Sanz, R., Díaz del Arco, C., Pingarrón, J. M., Fernández-Aceñero, M. J., Campuzano, S., & Barderas, R. (2023). p53 and p63 Proteoforms Derived from Alternative Splicing Possess Differential Seroreactivity in Colorectal Cancer with Distinct Diagnostic Ability from the Canonical Proteins. Cancers, 15(7), 2102. https://doi.org/10.3390/cancers15072102